Leflunomide may be associated with an increased risk of interstitial lung disease (ILD) in Korean patients

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2007年 / 1166卷 / 1期
关键词：
Public Health; Rheumatoid Arthritis; Arthritis; Corticosteroid; Early Diagnosis;
D O I：
10.2165/00128415-200711660-00011
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4 / 4
相关论文
共 50 条
  • [41] Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
    Cole, Alice
    Denton, Christopher P.
    CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2022, 8 (04) : 152 - 170
  • [42] Incidence and risk factors of interstitial lung disease (ILD) of head and neck cancer patients treated with Cetuximab
    Nakano, Kenji
    Taira, Shinichiro
    Ono, Makiko
    Tomomatsu, Junichi
    Sasaki, Toru
    Shimbashi, Wataru
    Fukushima, Hirofumi
    Yonekawa, Hiroyuki
    Mitani, Hiroki
    Takahashi, Shunji
    ANNALS OF ONCOLOGY, 2017, 28
  • [43] Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
    Alice Cole
    Christopher P. Denton
    Current Treatment Options in Rheumatology, 2022, 8 : 152 - 170
  • [44] Telomere (TL) shortening is associated with disease severity in scleroderma (SSC) associated interstitial lung disease (ILD)
    Adamali, Huzaifa I.
    Delgado, Cesar M.
    Stock, Carmel
    Lindhal, Gisela E.
    Molyneaux, Phil
    Russell, Anne-Marie
    Wells, Athol
    Renzoni, Elizabeth A.
    Maher, Toby
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [45] HEALTHCARE RESOURCE UTILIZATION AND ASSOCIATED COSTS OF PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE (PF-ILD) AND SYSTEMIC SCLEROSIS ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD) IN FRANCE.
    Nasser, M.
    Rabiega, P.
    Boussel, L.
    Si-Mohamed, S.
    Barbet, V
    Marque, S.
    Massol, J.
    Revel, D.
    Thivolet-Bejui, F.
    Chalabreysse, L.
    Maucort-Boulch, D.
    Jouneau, S.
    Hachulla, E.
    Cottin, V
    VALUE IN HEALTH, 2020, 23 : S717 - S718
  • [46] Chronic Cutaneous Lupus Erythematous (ccle) Associated Interstitial Lung Disease (ild)
    Patel, V. K.
    Bhatti, H.
    Ali, S. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [47] Risk Factors for the Exacerbation of Interstitial Lung Disease (ILD) after Administration of Biologic Dmards in RA Patients with Pre-Existing ILD
    Nakashita, Tamao
    Dibatake, Akira
    Matsumoto, Kotaro
    Hamada, Yoto
    Motojima, Shinji
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [48] Leflunomide-induced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis
    Sawada, Tetsuji
    Inokuma, Shigeko
    Sato, Takeo
    Otsuka, Takeshi
    Saeki, Yukihiko
    Takeuchi, Tsutomu
    Matsuda, Takemasa
    Takemura, Tamiko
    Sagawa, Akira
    RHEUMATOLOGY, 2009, 48 (09) : 1069 - 1072
  • [49] Fibrosing Interstitial Pneumonia Predicts Survival In Patients With Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD)
    Solomon, J. J.
    Ryu, J.
    Tazelaar, H.
    Myers, J. L.
    Tuder, R.
    Cool, C.
    Swigris, J. J.
    Brown, K. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [50] RISK OF MALNUTRITION IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD): FURTHER ANALYSES OF THE SENSCIS TRIAL
    Volkmann, E.
    Mcmahan, Z.
    Johnson, S.
    Smith, V.
    Jouneau, S.
    Miede, C.
    Alves, M.
    Herrick, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 674 - 674
12345